San Diego — Continuing to build on the firm’s dynamic Intellectual Property (IP) team, Rimon Law welcomes Dr. Dale Rieger as Partner in its San Diego Office.

Dr. Rieger joins Rimon Law from Jones Day, where he was Partner.

Dr. Rieger’s practice focuses on patent matters in the areas of biotechnology, chemistry, pharmaceuticals, bioinformatics, proteomics and medical devices. His extensive pharmaceutical understanding and experience brings a unique skillset to Rimon’s IP team.

Dr. Rieger counsels clients in all aspects of patent portfolio development, particularly in the field of chemistry including pharmaceuticals, agrochemicals, and polymers. He advises pharmaceutical and biotechnology companies regarding pharmaceutical life cycle management and Hatch-Waxman patent term extensions and litigation. He also advises corporate and venture investors on intellectual property due diligence associated with mergers and acquisitions, joint ventures, private and public financings, and initial public offerings.

“As we continue to build on our deep strength in the full range of IP law, we are happy to welcome Dale to Rimon. Dale’s extensive experience in pharmaceutical patent representations puts him at the forefront of the most important issues in IP law. Dale has helped clients create the most valuable patent portfolios, and he is a sought-after attorney in handling pharma sector transactions,” said Michael Moradzadeh, Rimon’s CEO

This month, Rimon also opened offices in Dubai, Berlin, and Sydney this month with the additions of Richard Ernest, Dirk Hamann, and Andrew Reilley respectively.

“I am very happy to join Rimon.  Rimon’s unique business model and track record of success is what attracted me to Rimon.  The ability to focus on client needs without the administrative burden of traditional law firms provides clients more efficient representation,” said Dr. Dale Rieger.

Dr. Rieger earned a J.D. from the University of San Diego, was an American Cancer Society Post-Doctoral Fellow at Harvard University, earned a Ph.D. in Organic Chemistry from Indiana University, and a B.S. in chemistry from the University of Minnesota.

Rimon is a highly selective international law firm, consistently recognized for its excellence, innovation, and teamwork throughout its 30 offices in eight countries and three continents. Rimon’s decentralized, distributed model allows for greater efficiency and collaboration to better serve our clients. Rimon’s Corporate Team possesses expertise spanning the spectrum of a company’s life cycle, advising companies ranging from early-stage enterprises to large public corporations, as well as financial institutions, on almost every type of corporate matter, and works closely with the Tax, Intellectual Property, Private Client, and Litigation Teams to assure full-spectrum representation and a deep level of coverage for our clients.

Rimon was named Alternative Law Firm of the Year for 2019 by The American Lawyer Magazine’s the Recorder. The firm has been repeatedly recognized by the Financial Times as one of North America’s most innovative law firms. The firm’s Managing Partners were both named ‘Legal Rebels’ by the American Bar Association’s ABA Journal and have spoken on innovations in the practice of law at Harvard and Stanford Law Schools. Rimon and its lawyers have also received numerous awards for excellence, including from Best Lawyers and Chambers.